Does Lexapro Cause TMJ?
No, Lexapro (escitalopram) does not directly cause temporomandibular joint disorder (TMJ/TMD), but there is limited evidence suggesting it may be associated with TMJ symptoms in some patients.
Evidence from Drug Labeling
The FDA-approved prescribing information for Lexapro does not list TMJ or temporomandibular joint disorder as a known adverse effect 1. The most common adverse reactions include insomnia, nausea, ejaculation disorder, sweating, fatigue, and somnolence—but TMJ symptoms are notably absent from the comprehensive adverse event profile.
Research Evidence on SSRIs and TMJ
Mixed Findings on Association
The research evidence presents conflicting data:
One observational study found a specific association: Patients prescribed citalopram (Celexa, a closely related SSRI) were more likely to report temporomandibular joint discomfort (p = 0.04), while interestingly, escitalopram (Lexapro) itself was not specifically evaluated in this analysis 2. This study examined 469 patients but found no overall statistically significant associations between SSRIs as a class and TMD symptoms.
Animal research suggests potential structural effects: In a rat model, escitalopram treatment in depression showed changes in TMJ characteristics, particularly affecting the superficial condylar head, with increased bone porosity and cartilaginous changes 3. However, animal models have limited direct applicability to human clinical outcomes.
Important Caveats
The key issue is distinguishing correlation from causation: Patients taking SSRIs like Lexapro often have depression or anxiety—conditions that are themselves strongly associated with TMD due to:
- Increased muscle tension and bruxism (teeth grinding/clenching)
- Heightened pain perception
- Stress-related jaw behaviors
- Psychological comorbidities that commonly accompany TMD 4
Clinical Interpretation
If a patient on Lexapro develops TMJ symptoms, consider these factors algorithmically:
Assess the temporal relationship: Did TMJ symptoms begin after starting Lexapro, or were they pre-existing?
Evaluate for bruxism: SSRIs can potentially worsen bruxism in susceptible individuals, which is a known TMD risk factor—this may be the indirect mechanism rather than direct joint toxicity.
Consider the underlying condition: Depression and anxiety themselves are risk factors for TMD, making it difficult to separate medication effects from disease effects.
Rule out other causes: TMD has multifactorial etiology including trauma, malocclusion, and parafunctional habits.
Management Approach
If TMJ symptoms emerge or worsen on Lexapro:
First-line conservative management should be implemented regardless of medication status, including jaw exercises, physical therapy, cognitive behavioral therapy, NSAIDs, and education about avoiding aggravating behaviors 4.
Do not discontinue Lexapro solely for TMJ symptoms unless there is clear temporal causation and symptoms are severe, as the psychiatric benefits typically outweigh this potential risk.
Screen for nocturnal bruxism and consider an occlusal appliance if present (though evidence for splints is conditional at best 4).
Consider switching SSRIs only if other measures fail and there is strong suspicion of medication-related exacerbation.
Bottom Line
The evidence does not support a direct causal relationship between Lexapro and TMD. The association seen in limited research is weak, inconsistent, and confounded by the underlying psychiatric conditions for which the medication is prescribed. Treat TMJ symptoms according to standard TMD guidelines rather than attributing them primarily to Lexapro use 4.